Tower Research Capital (TRC)’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-216
| Closed | -$30K | – | 4600 |
|
|
2018
Q2 | $30K | Buy |
+216
| New | +$19.6K | ﹤0.01% | 2186 |
|
|
2018
Q1 | – | Sell |
-663
| Closed | -$45K | – | 4240 |
|
|
2017
Q4 | $45K | Sell |
663
-646
| -49% | -$33.5K | 0.01% | 1415 |
|
|
2017
Q3 | $52K | Sell |
1,309
-191
| -13% | -$7.37K | ﹤0.01% | 1944 |
|
|
2017
Q2 | $60K | Buy |
1,500
+1,402
| +1,431% | +$51.3K | 0.01% | 678 |
|
|
2017
Q1 | $3K | Sell |
98
-1,097
| -92% | -$27.4K | ﹤0.01% | 2549 |
|
|
2016
Q4 | $21K | Buy |
+1,195
| New | +$25.7K | ﹤0.01% | 2114 |
|
|
2016
Q2 | – | Sell |
-300
| Closed | -$5K | – | 5343 |
|
|
2016
Q1 | $5K | Buy |
+300
| New | +$4.83K | ﹤0.01% | 2805 |
|
|
2015
Q4 | – | Sell |
-3,096
| Closed | -$57K | – | 5430 |
|
|
2015
Q3 | $57K | Buy |
3,096
+2,603
| +528% | +$65K | 0.01% | 929 |
|
|
2015
Q2 | $17K | Sell |
493
-1,029
| -68% | -$41.4K | ﹤0.01% | 2263 |
|
|
2015
Q1 | $73K | Buy |
1,522
+1,222
| +407% | +$55.4K | 0.01% | 1172 |
|
|
2014
Q4 | $7K | Buy |
+300
| New | +$6.92K | ﹤0.01% | 2508 |
|
|
2014
Q3 | – | Sell |
-3
| Closed | – | – | 5169 |
|
|
2014
Q2 | $0 | Sell |
3
-1,107
| -100% | -$28.1K | ﹤0.01% | 4969 |
|
|
2014
Q1 | $36K | Sell |
1,110
-317
| -22% | -$10.3K | ﹤0.01% | 1352 |
|
|
2013
Q4 | $34K | Buy |
+1,427
| New | +$39.9K | 0.01% | 1765 |
|
Tower Research Capital (TRC)'s FMI Position: Q3 2018 in Review
Tower Research Capital (TRC) sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 216 shares — an estimated $30K sold.
Tower Research Capital (TRC) first reported a position in FMI in Q4 2013 and held it in 14 quarters. The position peaked at $73K in Q1 2015. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Tower Research Capital (TRC) reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Tower Research Capital (TRC) sold 216 Foundation Medicine, Inc. shares in Q3 2018, an estimated $30K.
- Tower Research Capital (TRC) first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 14 quarters.
- Tower Research Capital (TRC)'s Foundation Medicine, Inc. position peaked at $73K in Q1 2015.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.